Ion channel gene therapy for smooth muscle disorders: relaxing smooth muscles to treat erectile dysfunction

Assay and Drug Development Technologies
Jonathan D Schiff, Arnold Melman

Abstract

The promise of gene therapy to treat diseases remains largely unfulfilled. Past setbacks and the complexity of the delivery systems used, in terms of both targeting the appropriate cells and inducing expression of products at therapeutic levels, thus far have prevented significant success for gene therapy. Smooth muscle disorders represent a unique target for gene therapy. In many cases, smooth muscle is readily accessible and, to induce a therapeutic effect, will not require very high levels of gene product expression. This allows a lower efficiency of gene transfer to be successful. With these important features in mind, we believe that naked DNA transfer of potassium ion channels represents a novel and successful way to treat smooth muscle disorders. Herein, we present a rationale for treating erectile dysfunction, a smooth muscle disorder of the cavernosal bodies of the penis, with naked DNA gene transfer therapy. By inserting the hSlo gene, which codes for Maxipotassium channels, into smooth muscle cells, we can improve smooth muscle relaxation in the corporal bodies and thus improve erectile function. This method of gene transfer has proven to be safe and effective for erectile dysfunction, and human trials are ongoing.

References

Apr 1, 1995·The American Journal of Physiology·M T Nelson, J M Quayle
May 15, 1998·The New England Journal of Medicine·I GoldsteinP A Wicker
Mar 31, 1999·International Journal of Impotence Research·P Kunelius, O Lukkarinen
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·H C ChampionP J Kadowitz
Oct 24, 2001·Biology of Reproduction·T J BivalacquaW J Hellstrom
Sep 12, 2002·Biology of Reproduction·Thomas R MageeNestor F Gonzalez-Cadavid
Apr 18, 2003·BJU International·M B ChancellorN Yoshimura
Jan 22, 2004·Current Urology Reports·George J Christ
Sep 17, 2004·American Journal of Physiology. Heart and Circulatory Physiology·George J ChristArnold Melman
Mar 10, 2005·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Howard D Pomeranz, Abdhish R Bhavsar
Mar 11, 2005·Advanced Drug Delivery Reviews·Alain Rolland

❮ Previous
Next ❯

Citations

Feb 9, 2007·International Journal of Impotence Research·K P DaviesA Melman
Nov 7, 2007·The Urologic Clinics of North America·Arnold Melman
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·William O BrantTom F Lue

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.